Imidocarb dipropionate (CAS 55750-06-6)

Imidocarb dipropionate is an organophosphate-based compound extensively used in research on protozoal infections caused by parasites like Babesia, Theileria, and Ehrlichia. Additionally, it is investigated in relation to select bacterial and fungal infections. Imidocarb dipropionate exhibits long-acting properties and a broad spectrum of activity against parasites. Imidocarb dipropionate has multiple physiological and biochemical effects. One of its mechanisms of action is the inhibition of acetylcholinesterase, an enzyme responsible for the breakdown of acetylcholine, a neurotransmitter involved in nerve impulse transmission. This inhibition results in increased levels of acetylcholine in the body, ultimately leading to the inhibition of nerve impulses. Moreover, it has been observed to inhibit phospholipase A2, resulting in elevated levels of arachidonic acid. Additionally, imidocarb dipropionate inhibits cyclooxygenase, leading to increased levels of prostaglandins. In vitro studies have extensively employed imidocarb dipropionate to examine its effects. It has been utilized to investigate its impact on cell proliferation and metabolism. Furthermore, researchers have explored its influence on the immune system and the nervous system.